Cargando…
Efficacy and Safety of Different Aerobic Exercise Intensities in Patients With Heart Failure With Reduced Ejection Fraction: Design of a Multicenter Randomized Controlled Trial (HF-EI Trial)
Background: Heart failure (HF) is one of the major causes of mortality worldwide, representing the terminal stage of several cardiovascular diseases. Exercise-based rehabilitation is a beneficial therapy for patients with chronic heart failure (CHF). However, there is a lack of specific guidance on...
Autores principales: | Shen, Ting, Liu, Xiaoling, Zhuang, Bo, Luo, Qian, Jin, Yishan, Li, Guanghe, Jiang, Yumei, Li, Dejie, Chen, Xianchuan, Tang, Nuo, Xu, Zhimin, Wang, Lemin, Zheng, Liang, Shen, Yuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427168/ https://www.ncbi.nlm.nih.gov/pubmed/34513951 http://dx.doi.org/10.3389/fcvm.2021.705972 |
Ejemplares similares
-
A Model for the Prediction of Mortality and Hospitalization in Chinese Heart Failure Patients
por: Zhuang, Bo, et al.
Publicado: (2021) -
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
por: Gronda, Edoardo, et al.
Publicado: (2020) -
Dementia‐related adverse events in PARADIGM‐HF and other trials in heart failure with reduced ejection fraction
por: Cannon, Jane A., et al.
Publicado: (2016) -
Representativeness of the GALACTIC‐HF Clinical Trial in Patients Having Heart Failure With Reduced Ejection Fraction
por: Mefford, Matthew T., et al.
Publicado: (2022) -
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
por: Jensen, Jesper, et al.
Publicado: (2019)